399 related articles for article (PubMed ID: 26176936)
61. Biomarkers, the control panel and personalized COPD medicine.
Agusti A; Gea J; Faner R
Respirology; 2016 Jan; 21(1):24-33. PubMed ID: 26172306
[TBL] [Abstract][Full Text] [Related]
62. Animal models of chronic obstructive pulmonary disease.
Fricker M; Deane A; Hansbro PM
Expert Opin Drug Discov; 2014 Jun; 9(6):629-45. PubMed ID: 24754714
[TBL] [Abstract][Full Text] [Related]
63. Chronic obstructive pulmonary disease: getting it right. Does optimal management of chronic obstructive pulmonary disease alter disease progression and improve survival?
Russell RE
Curr Opin Pulm Med; 2014 Mar; 20(2):127-31. PubMed ID: 24434666
[TBL] [Abstract][Full Text] [Related]
64. An index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary disease.
Moy ML; Teylan M; Danilack VA; Gagnon DR; Garshick E
Ann Am Thorac Soc; 2014 Feb; 11(2):149-57. PubMed ID: 24308588
[TBL] [Abstract][Full Text] [Related]
65. Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease.
Kirby M; Pike D; Coxson HO; McCormack DG; Parraga G
Radiology; 2014 Dec; 273(3):887-96. PubMed ID: 24960283
[TBL] [Abstract][Full Text] [Related]
66. Preventing hospitalization for COPD exacerbations.
Bourbeau J
Semin Respir Crit Care Med; 2010 Jun; 31(3):313-20. PubMed ID: 20496300
[TBL] [Abstract][Full Text] [Related]
67. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.
Niewoehner DE
Am J Med; 2006 Oct; 119(10 Suppl 1):38-45. PubMed ID: 16996898
[TBL] [Abstract][Full Text] [Related]
68. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
69. Positive association between two polymorphic sites (+134 insA/delA and G198T) of the endothelin-1 gene and chronic obstructive pulmonary disease. A case-control study.
Sampsonas F; Antonacopoulou A; Spathas D; Lykouras D; Kalofonos H; Flordellis C; Spiropoulos K; Siafakas N
Respir Med; 2010 Jan; 104(1):114-20. PubMed ID: 19640695
[TBL] [Abstract][Full Text] [Related]
70. [The potential role of proteomic and glycomic biomarkers in chronic obstructive pulmonary disease diagnostics].
Szabó M; Kun R; Hajba L; Koncz R; Guttman A; Csánky E
Orv Hetil; 2020 Jan; 161(4):123-128. PubMed ID: 31955582
[TBL] [Abstract][Full Text] [Related]
71. Personalized medicine and chronic obstructive pulmonary disease.
Wouters EF; Wouters BB; Augustin IM; Franssen FM
Curr Opin Pulm Med; 2017 May; 23(3):241-246. PubMed ID: 28257315
[TBL] [Abstract][Full Text] [Related]
72. Personalized Medicine in Respiratory Disease: Role of Proteomics.
Priyadharshini VS; Teran LM
Adv Protein Chem Struct Biol; 2016; 102():115-46. PubMed ID: 26827604
[TBL] [Abstract][Full Text] [Related]
73. Lung Disease and Genomics.
Wysocki K
AACN Adv Crit Care; 2018; 29(1):74-83. PubMed ID: 29496715
[TBL] [Abstract][Full Text] [Related]
74. Precision medicine in COPD exacerbations.
Agusti A; Faner R; Celli B; Rodriguez-Roisin R
Lancet Respir Med; 2018 Sep; 6(9):657-659. PubMed ID: 30029970
[No Abstract] [Full Text] [Related]
75. Integrating Transcriptomics, Proteomics, and Metabolomics Profiling with System Pharmacology for the Delineation of Long-Term Therapeutic Mechanisms of Bufei Jianpi Formula in Treating COPD.
Zhao P; Li J; Li Y; Tian Y; Yang L; Li S
Biomed Res Int; 2017; 2017():7091087. PubMed ID: 28424787
[TBL] [Abstract][Full Text] [Related]
76. Sex and Gender Omic Biomarkers in Men and Women With COPD: Considerations for Precision Medicine.
DeMeo DL
Chest; 2021 Jul; 160(1):104-113. PubMed ID: 33745988
[TBL] [Abstract][Full Text] [Related]
77. Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge.
Koutsokera A; Stolz D; Loukides S; Kostikas K
Chest; 2012 Feb; 141(2):396-405. PubMed ID: 21835899
[TBL] [Abstract][Full Text] [Related]
78. Precision medicine in chronic obstructive pulmonary disease.
Halpin DMG
Chin Med J (Engl); 2022 May; 135(10):1156-1162. PubMed ID: 35787584
[TBL] [Abstract][Full Text] [Related]
79. Multi-omics subtyping pipeline for chronic obstructive pulmonary disease.
Gillenwater LA; Helmi S; Stene E; Pratte KA; Zhuang Y; Schuyler RP; Lange L; Castaldi PJ; Hersh CP; Banaei-Kashani F; Bowler RP; Kechris KJ
PLoS One; 2021; 16(8):e0255337. PubMed ID: 34432807
[TBL] [Abstract][Full Text] [Related]
80. Impact of Biomarkers on Personalized Medicine.
Carrigan P; Krahn T
Handb Exp Pharmacol; 2016; 232():285-311. PubMed ID: 26330258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
